CP activation can result in allograft rejection following transplantation (20) but can also drive a number of autoantibody mediated diseases including neuromyelitis optica (NMO) (21, 22), generalized myasthenia gravis (gMG) (23, 24), and cold agglutinin disease (CAD) (25). Here, CP is linked to cold agglutinin disease.